Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05947266
Other study ID # NIMH34133481
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 1, 2024
Est. completion date June 30, 2026

Study information

Verified date May 2024
Source Florida International University
Contact MICHELE JEAN-GILLES, PHD
Phone 561-536-4186
Email gillesm@fiu.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is to test a culturally tailored engagement and retention intervention for Haitian Immigrants Living With HIV (HILWH). The main questions it aims to answer are: - Does this intervention result in measurable engagement and retention in care? - Does this intervention result in measurable viral suppression within 6 months? Participants will - participate in a pilot health intervention entailing 4 individual meetings, approximately once monthly over a six-month period and completing research questionnaires at enrollment, post-intervention and at 6 months post-enrollment. - Six participants who have completed the pilot intervention and agree to take part, will participate in the photovoice portion of the study. This activity will consist of 6 additional meetings where participants will be taught about using photographs to illustrate their experience participating in the study and take and display photographs.


Description:

Research design: The proposed study will test a culturally tailored engagement and retention intervention for Haitian immigrants living with HIV (HILWH). This is sequential mixed-methods formative pilot research that is designed to examine engagement and retention in care, and viral suppression (VS) for HILWH and adapt a promising intervention that will result in viral suppression between baseline and a 6 month follow-up assessment. The pilot will be conducted as a prospective, quasi-experimental single arm with a sample of newly diagnosed or nonvirally suppressed HIWLH adults drawn from 2 Federally Qualified Health Centers (FQHC) sites in Miami. Procedures to be used: AIM 1 mixed methods (quantitative and qualitative) data collection on barriers and facilitators to viral suppression among HILWH. Quantitative questionnaires will be completed by health care service providers and HILWH who will also participate in a Focus group. A sample of HILWH will participate in individual in-depth interviews. AIM 2 consists of a pilot health intervention entailing completing research questionnaires at enrollment, post-intervention and at 6 months post-enrollment. In addition, participants will have 4 individual meetings, approximately once monthly over a six month period. AIM 3 Photovoice participants will be 6 participants who have completed the pilot intervention (AIM 2) and agree to participate in the photovoice portion of the study. This activity will consist of 6 additional meetings where participants will be taught about using photographs to illustrate their experience participating in the study and taking photographs. This activity is expected to take approximately 8 additional hours over 2 and a half months. For these six participants, the total amount of time will be approximately 20 hours over 8 and 1/2 months.


Recruitment information / eligibility

Status Recruiting
Enrollment 66
Est. completion date June 30, 2026
Est. primary completion date December 1, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Seropositive for HIV 2. Either a recent HIV diagnosis (within the last 2 months) or non-virally suppressed. 3. Migrated to the US from Haiti Exclusion Criteria: 1. Virally suppressed

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
an adaptation of the iENGAGE
Haitian immigrant iENGAGE (H-iENGAGE) is an adaptation of the iENGAGE intervention culturally adapted for Haitian immigrants with HIV that will be tested in a quasi-experimental pilot for preliminary efficacy among recently diagnosed or nonvirally suppressed adults across two Federally Qualified Health Centers (FQHCs) in Miami.

Locations

Country Name City State
United States Care Resource, Inc. Miami Florida

Sponsors (1)

Lead Sponsor Collaborator
Florida International University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Care of Engagement Index Score Change in Engagement in Care score over time, including comfort and communication with provider Baseline, post-intervention (week 12 to 14 post baseline), 6-month post-baseline follow up
Primary Viral suppression Change in HIV load measurement toward a target of less than 200 copies/ml Baseline, 6-month post-baseline follow up
See also
  Status Clinical Trial Phase
Recruiting NCT05780073 - Safety and Impact of Dasatinib on Viral Persistence and Inflammation in People With HIV Under Antiretroviral Treatment Phase 2
Completed NCT05674682 - Seroincidence Study Among Men Who Have Sex With Men and Transgender Women - The ImPrEP Seroincidence Study N/A
Completed NCT03746457 - Alcohol and ART Adherence in India N/A
Recruiting NCT04663152 - Integrated Navigation Services for Treatment Adherence, Counseling, and Research N/A
Completed NCT02976259 - Kinetics of HIV-RNA Decay in Seminal Plasma of Men Treated by Dolutegravir at the Time of Primary HIV Infection Phase 3
Enrolling by invitation NCT05492565 - Seville Cohort of People at Substantial Risk for HIV Infection on Pre-exposure Prophylaxis
Completed NCT03387397 - Assessing Differential Adherence to Medications and Quality of Life Among People Living With HIV and Comorbidities
Completed NCT05383456 - The Visceral Adiposity Measurement and Observation Study